Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

Q3 2017 Earnings Call
Company Participants
FINAL

Luigi Lubelli, Chief Financial Officer
Spencer Horgan, Head of Investor & Rating Agency Relations

Other Participants
Andy Hughes , Analyst
James Shuck, Analyst
Mark Cathcart, Analyst
Michael Huttner, Analyst
Nadine van der Meulen, Analyst
Niccolo Dalla Palma, Analyst
Nick Holmes , Analyst
Paul De'Ath, Analyst
Peter Eliot, Analyst

Bloomberg Transcript

Thomas Seidl, Analyst

Presentation
Operator
Good day, and welcome to the Generali Group Nine Month 2017 Results Q&A session.
Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Spencer Horgan, Group Head
of Investor & Rating Agency Relations. Please go ahead, sir.

Spencer Horgan

{BIO 4241901 <GO>}

Hello, everyone, and welcome to our call on the nine months '17. We are going to have
around one hour for your questions this morning. We will finish just before 1 o'clock CET. I
know it's a very busy day for results today. I know that there is another call at 1 o'clock. So,
we will stop just before, to give you a few minutes to switch over.
With that I going hand over directly to Luigi for a few opening remarks and then we'll be
ready to take your questions.

Luigi Lubelli

{BIO 4108780 <GO>}

Page 1 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

Thank you, Spencer. And hello, everyone. Thank you from my side for joining the call with
us today.

FINAL

I hope that you have already been able to see our release this morning. Nonetheless,
please let me briefly highlight what I believe are the main takeaways. Our figures and
results continue to demonstrate the consistent execution of our strategy and our focus on
technical excellence.
Firstly, I would like to talk about our volumes. In Life, we recorded a further quarterly
recovery in premiums issuance, as we saw in the second quarter, which has taken our nine
months figure back to almost the same level of 2016. Of course, this is achieved while still
maintaining our selective product focus.
In flows are strong at 8.2 billion and here too we saw a further reduction in the gap
against 2016. Consistent with what you saw in the first half, this net new money is driven
by unit-linked and protection products.
Non-life continues to grow steadily at 1.4% with a notable increase in Motor, while NonMotor is closer to stable, with growth in EMEA and CEE, offsetting some reduction in
Global Corporate & Commercial business, especially in Italy.

Bloomberg Transcript

Moving to technical performance, in Life, the success of our actions to rebalance the new
business portfolio has had a strongly positive effect, with overall new business value
increasing by 57% year-on-year.
In Property & Casualty, our combined ratios remained outstanding at 93%, despite the
higher levels of natural catastrophe losses we endured. Prior year results are slightly larger
than in 2016, while as was the case in the first half, acquisition expenses are higher due to
our efforts to develop the Non-Motor business.
Lastly in the Holding and other segment, we continue to have a good contribution to the
operating results from Banca Generali, as well as from our asset management, real estate
and private equity businesses. A further good contribution came from the cost savings at
the Group head office.
The non-operating results show the pattern broadly aligned with the first half, contributing
positively to net profit growth, thanks mainly to lower impairments and decreased interest
payments. As I mentioned in the first half results, a slightly higher tax rate reflects a
smaller amount of tax-exempt income this year.
Our bottom line amounted to EUR1.5 billion for the first nine months. And here we saw the
effects of the previously announced loss on the disposal of our Dutch business. However,
our performance underlying this is a strong and encouraging one. The profit from
continuing operations grew by more than 7%.

Page 2 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

Lastly, our solvency position has strengthened once more, our regulatory ratio moved
from 178% at year-end to 1 95%. And on the full internal model view from 194% to 215%.
The improvement comes mainly from the strong normalized capital generation of the
Group, which continued at essentially the same pace as in the first half and from
variances, mainly as a result of the more benign financial market conditions we have
witnessed so far in 2017.
The final ratio then calculated again after deduction of the dividend and accrual, at the
pro-rata rate of last year's dividend paid of $0.80.
And with that I'm happy to take your questions.

Questions And Answers
Operator
Thank you. (Operator Instructions) We will take our first question today from Thomas Seidl
of Bernstein. Please go ahead. Your line is open.

Q - Thomas Seidl

{BIO 17755912 <GO>}

Bloomberg Transcript

Yeah. Thank you. Good afternoon. Two questions, first on -- maybe three questions if I
may. The first one is on Life operating result, it's down 15% versus Q1, Q2, you had already
pretty high expenses previously for your investment in Asia. So I wonder, what has been
driving this 15% drop and what it means for Q4 Life operating income?
Secondly on P&C, you commented a sharp drop in average premium in Italian Motor. I
think there is another 50 year of drop. And I wonder, what it does to your underlying
profits? You already commented I think that reserve releases are going to be even higher
than last year, but at what point basically do you think that this weaker underlying Italian
Motor margins are coming through?
And the third question is, could you please give an update where you are on the disposal
of the German Life business in terms of process? Are you making progress towards the
disposal, how should we think about the situation there? Thank you very much.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Good afternoon, Thomas. So, in terms of the fall in the Life operating results, I would say
that basically the expansion of the distribution network in Asia continues, it's something
we continue to work on. And it indeed had continued to have an impact in the third
quarter, plus traditionally there is some seasonality in this quarter. So it's a normally lower
than the previous ones.
Non-Life, in Italy, I wouldn't say there was any major difference in trend compared to the
first half. We continued to be very selective in our -- in the choice of risks and in the pricing
of them. And actually, the results are very good. The comment I made on reserve

Page 3 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

releases was -- which by the way, there is only a slight increase compared to a year ago,
was not referred specifically to Italy. I wouldn't say -- I wouldn't say that it was a driver of
the performance there. In Italy, we are increasing prices and we are observing a certain,
let's say, improvement in the overall market environment.
In terms of operating performance, Italy -- I mean it's not disclosed, but actually barring
the impact of natural catastrophes, it was quite good in the quarter. So we're actually
quite happy about the performance there.
I really have nothing to say about the disposal of the German Life business. You know we
are going ahead with a reorganization of the activities in Germany. We have put -- we are
putting I should say, Generali Leben into run off. And as we said when the news were
communicated, we are open to assess other alternatives for this company, but that's as
much as I can say on this one.

Q - Thomas Seidl

{BIO 17755912 <GO>}

(inaudible), said this morning that they have already received a couple of quotes, is that
also the stage you are at Generali Leben?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Bloomberg Transcript

Look, as I said, I -- that's what I can comment now at the moment. We will have news to
report on that we will.

Q - Thomas Seidl

{BIO 17755912 <GO>}

And maybe a follow up on the Motor Italian, you've commented in your press release, it's
a drop mainly due to the average premium in Motor and average premium are down 20%
over the last four or five years in Italian Motor. So, I just wonder what is going on there, are
we at a simply lower loss level and hence, this is sustainable or how do you think about
that?

A - Luigi Lubelli

{BIO 4108780 <GO>}

No, clearly, there has been a -- an intensely competitive environment. As far as we are
concerned on our new business, we are increasing rates. So we certainly -- as I said
before, we are selling selectively at appropriate prices, and we think the results of that will
be seen going on. We are quite happy about the performance in Italy. There is no specific
concern there, but there are moments in which the market is more challenging than other
and that has been the case in Italy.

Q - Thomas Seidl

{BIO 17755912 <GO>}

All right. Thank you very much, Luigi.

A - Luigi Lubelli

{BIO 4108780 <GO>}

You are welcome.

Page 4 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

Operator
We now take our next question from James Shuck of Citigroup. Please go ahead.

FINAL

Q - James Shuck

{BIO 3680082 <GO>}

Hi. Good morning. I also have three questions please. My first question around the capital
generation. So I think previously you guided to around 17 points of operating capital
generation across the year. My question is really around the new business profit, because
new business profit is up very strongly. So I should presume therefore that the capital
generation of 17 points is going to be higher, so if you just clarify whether that's the case
and if not, what's the offsetting impacts, please?
Secondly, around the -- I was looking at the (inaudible) and just looking at the solvency
ratios in the legal entities, I can see that 2016 by France and Italia have very high solvency
ratios at legal entity level, could you just clarify whether you are doing anything to try and
release that capital and upstream cash flow to the holding company, and if so, how long
that would take?

Bloomberg Transcript

And then, finally, improvement in the solvency ratio at the nine months, this year there
was a benefit from the BTPs. I am not entirely clear how you treat the BTPs in your internal
model. Obviously, I am pretty sure, you don't bring them in at BBB level in the solvency
capital requirements. But if you could just talk about how they are included and perhaps
the interaction with the VA in the period that would be very helpful? Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Hi, James. So, let's see, basically all your questions revolve around capital and contribution
to solvency. And actually, thanks for the question, because I think it's something that will
be in the minds of many today. In terms of the internal capital generation, we basically
continued at the same pace you saw in June. So we are basically maintaining the same
speed that you saw in June. So I am not making forecast for year-end, but basically we are
continuing along those lines, which is, as you correctly say, an outcome of the -- certainly,
the main driver is the margins of the new -- on the new business we are writing.
Just to illustrate, although the figures were not disclosed, I would say that that was the
bigger component, the relative -- in relative terms the bigger component of the internal
capital generation. Then we had the financial market variances and there is also some
contribution coming from the fact that we are increasingly applying a very careful selection
of investment based on risk-adjusted performance.
You said -- so regarding the other question, the BTPs have a capital charge in our model.
And we are using the dynamic VA and we are applying the same reference portfolio as
EIOPA.
Regarding the -- what we're doing about the companies, I mean nothing to report now. I
mean there is nothing we are specifically doing on France and Italy now, but yes of course
we are considering ways in which capital can be upstreamed in greater amount I should
Page 5 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

say because we already are receiving from this countries a significant part of our total
remittances. We are certainly looking at ways and approaches in which we can improve
the upstream of capital going forward. And that is something we'll update you about in
the future.

FINAL

Does this answer your question, James?

Q - James Shuck

{BIO 3680082 <GO>}

Well, not really. Can I just go back on a couple of things?

A - Luigi Lubelli

{BIO 4108780 <GO>}

No, just ask them. What's the part that's remained unclear?

Q - James Shuck

{BIO 3680082 <GO>}

So two points, one is, so the capital generation of 17 points that you're guiding to for the
current year, did that already take into account a very strong increase in new business
value or is the strong increase in new business value something incremental to the 17
points? That's the first point.

Bloomberg Transcript

And then the second point is, can you actually tell me what capital charge is on the BTPs
please?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Well, I cannot disclose that as part of our internal model, but I -- as I told you, the capital
generation from the new business was progressing at the same pace as in the first half.
So this contribution was basically similar to what you saw in the first half, the contribution
from new business.

Q - James Shuck

{BIO 3680082 <GO>}

Okay. That's helpful then. Thank you very much.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Okay.

Operator
Our next question today comes from Michael Huttner of JPMorgan. Please go ahead.

Q - Michael Huttner

{BIO 1556863 <GO>}

Fantastic. And so, three questions, one on the -- I think the difference between the
standard and internal model on solvency is that the three main countries Austria,
Switzerland and Spain, I just wondered, if you can talk about the progress on the internal
model for this?
Page 6 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

And the second is, it kind of relates to the two previous questions, your organic capital
generation is clearly very high and that's very attractive. But it's not -- there is still a big
disconnect to reported earnings and the reported cash flow. And I just wondered, when
you will provide an update of how one becomes the other or how quickly or how slowly
one becomes the other? That would be very useful.
The third point, at the six-month's stage, the underlying combined ratio so reported less
reservity spend on -- not to the less natural catastrophes, was 92%, at the nine-month's
stage is 91.2%. So there this being quite a sharp improvement, maybe I didn't do the
math, but it sounds like Q3 standalone is around 90. And I just wondered, which -- where
this relates to? How this relates to -- I mean which countries?
And then the final thing is, on France, you've said in the past, your wanted to expand
distribution and make it better. And I just wondered what your current thoughts are on
that? Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Okay. Hi, Michael.

Q - Michael Huttner

{BIO 1556863 <GO>}

Thank you.

Bloomberg Transcript

A - Luigi Lubelli

{BIO 4108780 <GO>}

So, with respect to the convergence of the regulatory model towards internal model, I'd
say there is nothing new with respect to what we reported as of the first half. As you
know, we are continuing to work on the inclusion of Spain, Austria and Switzerland plus the
operational risk. And basically, it's the same -- we would hope and think that over the next
three years some of these modules will be included in our internal model, but of course,
that depends on the approval by the supervisors. So that's basically is the same news as
we gave you as of the first half.
With respect to the organic capital generation, this is a legitimate and frequent question
and thanks for asking this again, because this, I also think is in the mind of many around
the phone. What I can tell you is that, it will clearly translate into larger operating profits
and stronger cash generation going forward. This is something we know we have to give
you a better disclosure about and we intend to do so with the full-year results, in which
hopefully we will be able to address this interest by the market in a more comprehensive
way.
You were asking me about the combined ratio, I cannot give you figures by countries. As I
said before, basically, there was -- if you compare it year-on-year, I mean I wouldn't over
blow this prior year development elements, because basically, yes it was larger but it was
not terribly larger. We also had a higher acquisition expense component compared to the
previous year. And basically, the two kind of erase each other. So the --

Page 7 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

I wouldn't say it distorts the perception of the combined ratio. The combined ratio was
affected by natural catastrophes. If you exclude natural catastrophes, the ordinary
business, the non-catastrophe business, was actually performing quite well in a few
places. So, there is basically the -- simply that the underlying, underwriting experience is
proving to be quite good. That's what we see.

Q - Michael Huttner

{BIO 1556863 <GO>}

And could you say which places maybe, or give examples?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Well, for instance, a country I mentioned before is Italy. So Italy has -- I mean we would not
disclose the figures, but Italy on its own has an increase in this combined ratio, which is
solely driven by the natural catastrophes and other than that, is actually doing quite well.
We would have had natural catastrophe impacts in several places. Notably, Germany was
an affected country as well. We had impacts on the commercial business from that.
But other than that, the performance -- France is a country -- France is one of -- possibly is
one of the -- as was the case in June, is one of the positive swinging factors of the year.
France is doing quite well in terms of combined ratio, and it's a large country. So I would
say that is clearly one of the positive drivers.

Bloomberg Transcript

Talking about France -- sorry you can --

Q - Michael Huttner

{BIO 1556863 <GO>}

Yeah. No, exactly. Sorry.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Talking about France in distribution, -- distribution, what we're doing there is we are taking
a close look at the profitability per channel. So we want to make sure that we get good
business in terms of risk adjusted performance from each channel. And -- but we are also
ambitious again about agents' distribution, so we are quite willing to reinforce our agents'
distribution footprint in the country.

Q - Michael Huttner

{BIO 1556863 <GO>}

Would you consider buying a large network or is this more piecemeal?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Well, we will -- I'd say that, for the moment, we are rather looking at organic -- including
the agents workforce [ph] .

Q - Michael Huttner

{BIO 1556863 <GO>}

Okay. Thank you very much. Thank you.

Page 8 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

A - Luigi Lubelli

{BIO 4108780 <GO>}

You're very welcome.

FINAL

Operator
We will go to the next question, which comes from Nick Holmes of Societe Generale.
Please go ahead. Your line is open.

Q - Nick Holmes

{BIO 3387435 <GO>}

Hi, there. Thank you very much. Couple of questions. First is, wondered Luigi if you could
elaborate a little bit more about the benefits of a disposal of the German life book versus
a runoff, I mean purely in concept and theoretical, wondered what the attractions would
be?
And then, secondly, just looking at your unit linked, I mean this is really booming. And I just
wondered, how sustainable, do you really think this is? Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Bloomberg Transcript

Hi, Nick. This -- your first answer is one that is honestly, not easy to answer in lack of a
concrete example, because it's -- this is only theoretical , if we had a disposal scenario in
front of us to compare to, then I could be more precise. I would say that, we clearly have
concluded that the runoff is beneficial and we have a very clear idea of the benefits that it
will bring overall in terms of how we can manage that portfolio and how we can ensure
the resilience to future stressful interest rate environments.
I'm not breaking any extraordinary news by saying that clearly, we would entertain that
possibility if whatever came from outside where clearly better than what we -- than what
we can do on our own, but at this moment, I'd say, that would be the answer to your
question, not having the specific example -- the specific concrete disposal opportunity in - before me, right. So --

Q - Nick Holmes

{BIO 3387435 <GO>}

Yeah. No, that's very fair, fully understand that. Yeah.

A - Luigi Lubelli

{BIO 4108780 <GO>}

And the booming unit linked, well, it is. Where can it stop? It's difficult to say, because
clearly this is our sales orientation and I -- and as you can imagine, we are very pleased
with what is happening, which is nothing but the outcome of -- because you've seen this
quarter-after-quarter-after-quarter for over a year now. And this is the outcome of a very
precise strategy execution across many countries.
I'd say that, we are having a -- we're especially pleased about the performance in Italy
and France. In Italy sales of unit linked are doing specially well, but France is at very similar
levels in terms of growth. And look, I think it boils down to the attractiveness of the
products and the effectiveness of our network. I said it, for the moment, this is the sales
Page 9 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

outlook we have for what we can see now, we will continue along this trend. I don't see
any reasons for the moment to see any variation in terms of how our inflows will come to
us.

Q - Nick Holmes

{BIO 3387435 <GO>}

FINAL

Great. That's very clear. Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

You're welcome.

Operator
Our next question today comes from Nadine van der Meulen from Morgan Stanley. Please
go ahead.

Q - Nadine van der Meulen

{BIO 15200446 <GO>}

Bloomberg Transcript

Yes. Good morning and thank you for taking my questions. I've got a question on the
capital side. So capital comp piece to strengthen the regulatory, yeah, so obviously is now
close to 200%, economic now at 215%. And what is your ideal level? Yeah. So, above
which level would you consider to have excess? And in that light, perhaps also a question
on your leverage. You've commented previously that you -- probably I remember well,
were proactively looking at reducing your leverage in the near term. Has that changed?
And then a last question, just a quick one on the investment income, so the current return
dropped a bit in Q3, at 2.3% versus the first-half 3.2, what's the particular reason for it and
what level should we expect going forward? Thank you very much.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Hi, Nadine. Interesting questions, so let's see. Firstly, we have not yet commented openly
about a level which Generali considers a number above which we have an excess. This
clearly I -- your question is very fair. This is a kind of analysis that we are, as you can
imagine, performing internally. I would say that it's good to have to talk about excess
capital. So this is something we clearly are pleased about. It's also true that we are, I
would say, in the infancy of Solvency II and we have to -- this year looks this way, last year
looked in a different way. So there is a certain element of volatility with which we -everybody has to get familiarized in order to say this is a level above which we would find
ourselves in a solid excess.
What I can tell you is that something we certainly are looking at, and it is likely that we will
tell you more about this in the future. Actually, I don't recall saying that we were
decreasing our leverage. What we have always said that we did not want to increase the
stock of that. The factor, given that the equity and capitalization of the Group is improving,
that means that gradually -- and actually it's a fact, if you look at our leverage figures over
the last three years, they have been falling precisely because the debt has been stable.

Page 10 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

But we have not announced any action about an actual reduction of the amount of debt,
which continues to be around EUR12 billion.
Your question on investment income, I think you were referring to figures that were not
annualized. I would say that in terms of what we are observing in the accounts, as was the
case in June, we are experiencing a better reinvestment rate in the Non-Life business. We
saw that in June and we're seeing that again in the first nine months. In terms of the Life
business, the reinvestment rate continues to be below a year ago, but that difference is
narrowing, in the sense that we are seeing an improvement in reinvestment rates there
as well, although we have not yet recovered to the levels of the previous year. I wonder if
this answers your question?

Q - Nadine van der Meulen

{BIO 15200446 <GO>}

Yes, it does. And with the debt reduction, that's exactly what I meant, that during the past,
that you wouldn't -would not proactively take action on that front. And I was just wondering whether in the
current situation, your thoughts have changed on this?

A - Luigi Lubelli

{BIO 4108780 <GO>}

No, there is nothing compared to previous conversations we had on this one.

Bloomberg Transcript

Q - Nadine van der Meulen

{BIO 15200446 <GO>}

Okay. Thank you so much. Very clear.

A - Luigi Lubelli

{BIO 4108780 <GO>}

You are welcome.

Operator
Our next question today comes from Mark Cathcart of Jefferies. Please go ahead. Your
line is open.

Q - Mark Cathcart

{BIO 1891927 <GO>}

Yeah. Hi. In relation to Solvency II excess capital, the key point has going to be what your
sensitivity now is to interest rates. And surely, if your sensitivity comes down, and you've
got a Solvency II ratio verging on 220%, you've indeed got excess capital. So given the
fact that you put Generali Leben into runoff, can you confirm that at least that would
decrease your Solvency II sensitivity to interest rates?
The second question is, last November, the CEO gave us a nice pointer towards the cash
remitted going up by more than 10% for the full year. Surely you can say that it will at least
be 10% given the 53% increase in (inaudible).

Page 11 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

And then the final point is, in terms of your disposal program, you're shooting for over a
billion. I just wondered where are you at the moment in terms of how much capital you've
actually released from the non-core disposals? And can you confirm that it will indeed be
nicely over 1 billion when it's all said and done, please?

FINAL

A - Luigi Lubelli

{BIO 4108780 <GO>}

Okay. So let's see, I am trying to go back to your question, I mean the -- it's by -- you said
by selling Generali Leben or by putting Generali Leben into runoff ?

Q - Mark Cathcart

{BIO 1891927 <GO>}

Yeah, by putting Generali Leben into runoff, surely that will decrease your sensitivity to
interest rates. I mean that's a given.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Well, it certainly has increased our ability to withstand the variation in interest rates,
because clearly the capitalization in Germany was greatly -- will be greatly enhanced by
this transaction. So yes, indeed, we have a greater ability to withstand variation -- the
negative variations in interest rates. You had some question on excess capital?

Bloomberg Transcript

Q - Mark Cathcart

{BIO 1891927 <GO>}

Yes. So, I guess that points to the fact that it's going to be much easier for you to show a
position of excess capital because the Solvency II level that you wish to be at, say whether
it's 210 or 220, before you declare excess, the lower your sensitivity to interest rates, the
lower that number can be. So I'm suggesting that actually this is a key issue for you that
put it into runoff. So, it suggests that you are indeed now in the position of excess capital.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Excess capital depends with respect to what? I mean, clearly the -- it depends where you
want to take your questions. I mean, clearly it is evident that the economic solvency of the
Group has improved considerably. So that is a fact. If your question is whether that is
having -- I'm trying to read your question, if your question is, whether this is having any
impact on what we plan to do with respect to dividends, the answer would be, no. In the
sense we have a plan. We have a commitment to the market by 2019 and for the moment
that will not change.
And we clearly have a business plan update by the end of next year and we'll tell you
more about what we're going to do forward at that time. Is that what you wanted to ask,
Nick?

Q - Mark Cathcart

{BIO 1891927 <GO>}

Mark.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Mark. Sorry Mark. I got -Page 12 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

Q - Mark Cathcart

{BIO 1891927 <GO>}

That's okay. And in relation to the cash -- the cash remitted, can you give some sort of
commentary on the cash remitted please? In other words --

A - Luigi Lubelli

{BIO 4108780 <GO>}

FINAL

Well, you said, something about 10% increase. I don't know exactly what you are referring.

Q - Mark Cathcart

It was really a year ago at the Investor Day, the CEO suggested that your remittance was
up some double digits amount as at the nine months' stage. I am just wondering, if you
could give us similar guidance now to just to confirm that actually your remittance is still
(inaudible) away, like it was last year. And so, therefore, meaning your run on track for
beating nicely your billion target for the full year period?

A - Luigi Lubelli

Bloomberg Transcript

{BIO 1891927 <GO>}

{BIO 4108780 <GO>}

Yes. Look, last year, we had indeed a very strong increase in cash remittance, about 20%.
So that is something that is certainly a challenging increase to repeat, I would say. Was
already very large a year ago. We are continuously and consistently working on increasing
our remittance. I cannot tell what figures there will be for 2017, but it's certainly something
we aim to raise. More importantly I was answering before another question of a similar
nature, we clearly are looking at ways in which the upstreaming of capital from our
subsidiaries can be enhanced. Going forward, that's something we are actively working
on. And when the right time comes, we will be updating you about that. I am right that you
had another question, Mark?

Q - Mark Cathcart

{BIO 1891927 <GO>}

Yeah. It was in relation to, where are you in relation to your 1 billion program or just
confirming that (inaudible) you would be over 1 billion that you're releasing overall please?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Yes, look, we have not yet given an update in terms of amount, except for the amount
that was known about the Netherlands, which was 140 million. And because with the
target -- just to remind everyone, the target we gave was in cash proceeds. So in terms of
cash proceeds, we have those coming from the operations, we already sold and -- but
disclosure was given specifically only about the Netherlands.
I mean qualitatively what I can tell you, we are, I would say, quite pleased about the way in
which the -- sorry, the disposal process is going on. We are working on all the companies
we had in mind. We have already announced this year a few transactions and we are
confident that over the next few months, we'll be able to announce new developments.
So that's what I can tell you so far and we remain confident about what we announced to
the market.

Q - Mark Cathcart

{BIO 1891927 <GO>}
Page 13 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

And when you show your Solvency II ratio that is not pro forma for what has been
announced, but not actually completed?

A - Luigi Lubelli

{BIO 4108780 <GO>}

FINAL

No.

Q - Mark Cathcart

{BIO 1891927 <GO>}

That's great. Okay. Thank you, Luigi.

A - Luigi Lubelli

{BIO 4108780 <GO>}

You are welcome.

Operator
Our next question today from Peter Eliot of Kepler Cheuvreux. Please go ahead. Your line
is open.

Q - Peter Eliot

{BIO 7556214 <GO>}

Bloomberg Transcript

Thank you very much. Had a couple of quick follow-ups, please. And then one new
question. First of all, the Life operating result, Luigi, you mentioned seasonality and you
mentioned the investments, obviously, seasonality is one-off. Should we expect the
investments to fall away as well, or can you give us any guidance to what the underlying
performance we should expect going forward?
Secondly, on the economic and regulatory model convergence, you mentioned the three
years, are you able to give us any sort of better guidance on -- for the next year or two to
(inaudible) anywhere where you are close to securing approval?
And then, finally, can I ask on the 13% growth in third party assets under management. I
mean you mentioned, you attributed that to Banca Generali in your release. I was
wondering if you can give any comments on how your initiative is progressing that you
announced with the Q1 results, and whether you're seeing anything there that you can
comment on yet? Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Hi. So, yes indeed -- well, you're asking when that will stop. I mean if anything, we are
certainly very committed and stepping up our efforts to increase our distribution capacity
in Asia. I would say that, if you look at our figures, if you look at our figures, in terms of the
new business values, what we are achieving in that part of the world is very encouraging,
and actually we expect that to continue delivering goods going forward.
So, honestly, I do not have a date in mind. I mean it's a -- these are large places.
Especially, China is a place where we are expanding our distribution in several provinces. I
cannot tell you, if that's a small -- faster or slower pace, but for the short-term, I would
Page 14 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

say, it will continue. I don't have a specific date to give you as a reference. In terms -- as I
said honestly and please understand that there is no guidance we can give you on the
approvals of internal models additions because they are beyond our control. So that's an
ongoing debate we have with the supervisory authorities.
And -- but honestly it's something that's -- it's impossible to give a guidance about. So,
what we can give you guidance about is about our efforts. And so, we're clearly supplying
all information and evidence as required by the authorities on each extension that we
want to achieve. And so, there is certainly no shortage of effort on our side to achieve
that, but there are some times that have to be followed and clearly, the supervisors are
sovereign in that.
With regards to the asset management, indeed Banca Generali was a very strong driver.
Actually, it was the development in assets under management was especially good
because basically in the third quarter, we kind of achieved as much as we have achieved in
the first six months. So this quarter has been very good on that front.

Bloomberg Transcript

But I understand your question was about the update on our asset management strategy.
We are doing what we said we were doing. So, we are working on securing agreements
with asset managers from multi-boutique arrangements. We are reorganizing the
companies we have in the Group to -- in this business. We are strengthening our teams
and we are reviewing the management line. So I would say that basically -- I mean, it's not
being such a long time, it's been basically six months since we announced that, but during
this six months, we have been working relentlessly on that. And with the full-year results,
we'll shortly be able to give you an update on what we have achieved in the year.

Q - Peter Eliot

{BIO 7556214 <GO>}

Okay. Thanks a lot.

Operator
Now, we will move onto our next question, which comes from Paul De'Ath of RBC. Please
go ahead. Your line open.

Q - Paul De'Ath
Yeah. Hi there. Thanks. Couple of quick ones from me please. And firstly on the P&C
business, Non-Motor is obviously your focus and the expense ratio has increased slightly
due to investments to try and grow that business. yet it's growing slower than Motor still.
When do you think you can -- we can expect to see some positive growth coming through
in Non-Motor? And that's question one.
And then, the second point was just following up on the 1 billion of cash proceeds target.
And I am not sure whether you will answer this, probably not, but is it possible to know
whether or not a sale of Generali Leben is within the plan to get to 1 billion or whether that
is on top of these plans? And so, if you sell Generali Leben then -- during the year, you are
going to be well over 1 billion? Thanks.
Page 15 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

A - Luigi Lubelli

{BIO 4108780 <GO>}

FINAL

Hi, Paul. Let's see. The fact, the two things are not necessarily related, in the sense that
Non-Motor includes both the retail business and the commercial business. So commercial
business this year is falling and that's especially pronounced in Italy. And so that clearly
detracts from the development of the overall figure of the Non-Life, Non-Motor business.
For instance, that business is progressing very well in the C, in terms of development, it's
developed -- it's developing very well in Europe Assistance, in terms of figures.
So, we are actually achieving results and in Italy, we're certainly making efforts in terms of
products, in terms of customer awareness, and in terms of incentives to the network. So
similar efforts, we're also undertaking in France. So, we're actually confident that we will
achieve that, but as I say, the lever of the G&C business is such that if it decrease this
year, it overshadows whatever improvement we may achieve on the retail side.
Regarding your other question, Generali Leben sale was not contemplated at the time we
announced our targets, so clearly would logically be on top of the amount we announced.

Q - Paul De'Ath
Excellent. Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Bloomberg Transcript

Welcome.

Operator
Our next question today comes from Nicco Dalla Palma of Exane BNP. Please go ahead.
Your line is open.

Q - Niccolo Dalla Palma

{BIO 16052945 <GO>}

Yeah. Good afternoon, everyone. So my first question is on the new business value. You
comment that the improvement is also a result of the economic scenario, which is
showing a slight recovery. Does it mean that financial assumptions changes did have an
impact in Q3 unlike H1 or does it actually mean your operating assumptions improved for
all the nine months, thanks to your economic scenario? I am trying to (inaudible) both the
financial assumptions that changed or the operating ones as effect of the economic
scenario?
The second question is, could you share even if the -- via ranges or indicatively what the
duration assumptions are roughly for hybrid products and did they change at all following
a couple of years experience or now three years of experience of selling these?
And thirdly, on products, we clearly know the names of some of the flagship products
you're selling in Italy from Valore Futuro, Equilibrio, Valore and the new Peer. Is there
anything you can tell us in terms of mix of inflows on these, just to understand, is it Valore
Futuro still taking the lion's share or if the others are now having a good success?
Page 16 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

A - Luigi Lubelli

{BIO 4108780 <GO>}

Hi, Niccolo. So, I'm afraid your questions maybe a bit too detailed in terms of the level that
we cover here. In terms of the assumptions, I would say, that we gave you some
information as of the first half. And you have variations by quarter, but frankly, they were
minor and they were erasing each other. Year-on-year, the reality is that management
initiatives are overwhelming in the improvement of the margins. In terms of financial
assumptions, are marginally helping if you compare them year-on-year, but the lion's
share, and it's the best way to say, to Generali comes from management initiatives.
I'm afraid that the questions you're asking on the products are a bit too detailed, and
some of them are proprietary. So I cannot necessarily disclose them. What I can tell you is
that, we are very pleased with the performance of the products we launched this year.
They are doing very well. We are especially happy with the sales that, for instance, we are
achieving through Banca Generali, for instance in terms of distribution channels, but
generally speaking throughout the network, we are very satisfied about our sales
performance.
Third quarter was a good quarter. The response of the network and the customers to our
products is very good. So, actually Italy is one of the countries we are most pleased about
in terms of performance this year. And clearly, the new products play an important part in
that.

Bloomberg Transcript

Q - Niccolo Dalla Palma

{BIO 16052945 <GO>}

If I could just ask, the -- when Banca Generali sells life new business, that's not included in
the life new business value of your Life division, right, because it's -- it's in the other part?
Just understanding both for new business value and for inflows, is it included even though
the profit goes in the other divisions or not?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Look, obviously, to the extent that it's a Generali company underwriting the business, it is.

Q - Niccolo Dalla Palma

{BIO 16052945 <GO>}

But then the profits would end up in the non -- not in the Life division, but in the others?
Just understanding, because I -- so we have the new business value in Life --

A - Luigi Lubelli

{BIO 4108780 <GO>}

There are two lines of business, one is the insurance companies and the other is the bank.
They contribute different streams of profit to the consolidated accounts. So whatever
pertains to the Life -- to the life insurance companies is reflected in the life insurance
company, and which is generated in Life. And then, clearly, there is a stream of revenues
that the bank is obtaining, especially in terms of fees and that is reflected in the Holding
and other activities line.

Q - Niccolo Dalla Palma

{BIO 16052945 <GO>}

Page 17 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

So that means that when you single out Banca Generali in operating result, it's not
everything. There's other bits that goes into Life business?

A - Luigi Lubelli

{BIO 4108780 <GO>}

FINAL

Of course, we only reflect what comes from the bank's accounts as consolidated into our
accounts.

Q - Niccolo Dalla Palma

{BIO 16052945 <GO>}

Okay. Thanks.

Operator
We now take our next question, which comes to Andy Hughes of Macquarie. Please go
ahead. Your line is open.

Q - Andy Hughes

{BIO 15036395 <GO>}

Bloomberg Transcript

Hi. guys. Couple of questions, one on the P&C business, I guess I struggle with the 93
combined ratio and the kind of rather weak top line. Is your combined ratio coming from
(inaudible) business you sold two or three years ago? And the kind of new business you
are writing is less profitable, because obviously if you are saying this is the way, it's
suggests there is a level of competition in the market, which means you're making huge
margins on the P&C book?
And the second question was about capital and dividends into Group, which I think a lot of
people are focused on. I would so Generali had a kind of heavy guarantee, the Italian
business is running off generating huge amount of surplus every year. And you suggest
that that's not the case, that a lot of your surplus generation is coming from this, basically
on new business, which opens up two questions, one is the kind of surplus you are
generating on the Group level is from this, that really is a going to turn into Group
dividends anytime soon because you are hit by the local GAAP restrictions on paying
dividends back to Group?
And the second is, the quality of capital will be deteriorating as well. So to what extent
should we actually look at this Group Solvency ratio and the operational cash generation
that you are producing? Because it doesn't seem entirely relevant for any dividend
metrics that might come out at any point. Thank you.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Okay. So good afternoon. Andy. Let's see. You struggled to see it and I struggled to see
your point. So, what I can see is that firstly, our premium volumes are growing and that is a
fact. So, overall, I wonder if you are actually referring to a specific country, but overall,
Generali is growing and this growth is coming especially from the Motor side and that is a
fact. So our top line is going up.

Page 18 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

So, secondly, as you know, we have been focusing on our technical excellence which is a
manifold in terms of aspects we are touching. It's a matter of selection, it's a matter of
pricing, it's a matter of handling claims, it's a matter of service provision, it's a complex
multi-pronged effort that we are undertaking in this business.
And, if anything, what we are seeing at Generali is an improvement in the underwriting -not only an improvement in the underwriting performance, we are also seeing a resilience
in our underwriting performance because actually, we continue to remain steadily at levels
which are industry leading. So from my point of view, actually, we do have both growth
and underwriting performance improvement.
Competition, there is and there always will be. And it's a different levels in various
countries. Somehow I sense that you may be referring more to Italy, perhaps because
indeed Italy is a country where we -- it's basically the only place where we have seen a
Generali -- Italy and commercial business are the places where you are seeing material
contractions in terms of premiums, which as I say, are more than compensated by growth
elsewhere.
But even in Italy, even with the reduction in premiums the underwriting performances is
very strong. Actually, one of the strongest we have in the Group. So, I just don't -- I do not
understand what angle you are coming from.

Bloomberg Transcript

Q - Andy Hughes

{BIO 15036395 <GO>}

Well, as you say, Italy is fine, if it's got a very good combined ratios, why are you shrinking
the book?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Look, it's not that we are intentionally shrinking the book. We are selective in the business
we buy. So we are not prepared to write business at any price. And so we focus on
maintaining the quality and the technical result of our business and we are quite
determined at that and we prefer to add some business, if it's not good enough for us.
That's what we're doing in Italy. But we are not deliberately shrinking the business, not at
all. We are as competitive as it gets at the right times.

Q - Andy Hughes

{BIO 15036395 <GO>}

Okay. And on the capital side?

A - Luigi Lubelli

{BIO 4108780 <GO>}

So on the capital side, I have to say, I also have some confusion there. Look, we do have a
good business from the past, yes. It is generating profits., yes, as well, but we are also
and hopefully it's showing powerfully, I would say in our figures, we're also working on
writing new business that will be even better in the future. The business is better because
it's between mix, it's better in terms of loadings, it's better in terms of guarantees and it's
less capital consuming than the business we had in the past. So it's true that Generali has
written very good business in the past, but it's also true -- I mean actually in my humble
Page 19 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

FINAL

view, if anything, we are laying in a very structured and precise way the grounds for an
even better profitability and internal capital generation going forward.
So if this, as we believe will deliver the outcome, we are writing the business for, it will
certainly have great internal capital generation, which means will add Tier 1 to the Group.
And as I said before, eventually rather -- over time rather than eventually, this would also
translate into greater capital generation -- I guess cash flow generation and remittance
from subsidiaries.
You are right in pointing out that I shared with you that there are local restrictions to that,
but I think also in that regard, we have quite some consistency in terms of the increase in
remittance over the last year.

Q - Andy Hughes

{BIO 15036395 <GO>}

Bloomberg Transcript

I'm just trying to work out in terms of your comments about how the Group capital
generation is coming from new business and this, contrasting that with the fact that the
inter-Group transfers I think are coming from the back book, where the earnings are
coming from. So, I don't dispute with your comments about the nature of the business
you are writing today, but what I don't see is the connection between having a (inaudible)
contract which makes profits over the next 20 years, and how that would necessarily
contribute to high inter-Group transfers even though it adds to a little bit of surplus
generation at the Group in terms of Solvency II. And so I guess my point is that, although
you are adding Group surplus, are you really adding inter-Group dividends?

A - Luigi Lubelli

{BIO 4108780 <GO>}

Well, that's what I was trying to answer to you before, in the sense that, I mean, if you
expect the new business volume to be on day one cash and immediately remitted
upwards, that's not going to be the case. So, that is -- but that I think is fairly obvious. The
-- what we are working on is on laying the ground for a consistent recurring and increasing
cash remittance from our subsidiaries going forward. But, of course, it takes years to do
so. To some extent, the recent element in which -- which I wonder if it answers your point,
but it certainly is a case, of course, let's say that you had some restrictions on your ability
to -- let's, say you have the cash, but you are restricted in your ability to upstream the
cash because of capital, clearly, if you generating more capital -- but we are talking at local
level here, going upwards, clearly if you are generating more capital locally, it does
increase your room and ability to use the cash flow for upwards payment. I wonder if that
answers your question?.

Q - Andy Hughes

{BIO 15036395 <GO>}

I mean, I didn't -- I think we are kind of agreeing with each other anyway, but all I am
asking for is when you do reveal disclosure on the capital side, if you could do something
that would give us a hint as to how we can get through remittances because adding more
VIS [ph] at the Group level or even adding more VIS into the capital locally isn't necessarily
going to drive the remittances higher. It's things like what happens is, assets are in
Germany, what happens locally -- obviously as James pointed out before, you've got
some pretty well capitalized local subsidiaries, if you write more Italian Life business that

Page 20 of 21



Company N ame: Assicuraz ioni Generali SpA
Company Ticker: G I M Equity
Date: 2017-11-09

has big VIS, is that going to translate into bigger dividends from Italy? I'm not sure in the
short term it does. And so that would be very helpful.

FINAL

Okay. As I said in the beginning of the call today, that point is well taken from the
contribution of the many of you to the dialog with us in this and in previous meetings and
we will -- we're working on an enhanced disclosure for the full year results so to help you
understand this better.
Thank you very much.

A - Luigi Lubelli

{BIO 4108780 <GO>}

Welcome.

Operator
That will conclude the question-and-answer session. I would now like to turn the call back
to Mr. Spencer Horgan for any additional or closing remarks.

A - Spencer Horgan

{BIO 4241901 <GO>}

Bloomberg Transcript

Yeah. Thank you everybody for joining us. As I mentioned at the beginning, we do need to
draw the call to a close now. I know there are still a couple of questions in the queue that
we didn't get to, apologize for that. But obviously myself and the Investor Relations team
will be happy take your questions afterwards. And with that, we wish you a good rest of
the day. Thanks. Bye

Operator
That will conclude today's conference call. Thank you for your participation, ladies and
gentlemen. You may now disconnect.

This transcript may not be 100 percent accurate and may contain misspellings and other
inaccuracies. This transcript is provided "as is", without express or implied warranties of
any kind. Bloomberg retains all rights to this transcript and provides it solely for your
personal, non-commercial use. Bloomberg, its suppliers and third-party agents shall
have no liability for errors in this transcript or for lost profits, losses, or direct, indirect,
incidental, consequential, special or punitive damages in connection with the
furnishing, performance or use of such transcript. Neither the information nor any
opinion expressed in this transcript constitutes a solicitation of the purchase or sale of
securities or commodities. Any opinion expressed in the transcript does not necessarily
reflect the views of Bloomberg LP.  COPYRIGHT 2022, BLOOMBERG LP. All rights
reserved. Any reproduction, redistribution or retransmission is expressly prohibited.

Page 21 of 21

